Receptor Mediated Uptake of Peptides That Bind the Human Transferrin Receptor
Overview
Authors
Affiliations
A biopanning process designed to find peptide epitopes specific for cell surface receptors has been used in this study to select seven- and 12-amino-acid peptides capable of binding to and internalizing with the human transferrin receptor (hTfR). Through sequential rounds of negative and positive selection, two peptide sequences were identified that specifically bind to the hTfR. Phage containing the sequences HAIYPRH or THRPPMWSPVWP were inhibited from binding the hTfR in a dose-dependent fashion when peptides of the same sequence were present in a competition assay. Interestingly, transferrin did not compete with either of these sequences for receptor binding, suggesting that these peptides bind a site on the hTfR distinct from the transferrin binding site. When either of these sequences was expressed as a fusion to green fluorescent protein (GFP), the recombinant GFP molecule was internalized in cells expressing the hTfR. These studies suggest that the two peptides can be used to target other proteins into the endosomal pathway. Further, they provide a strategy for identifying peptides that bind to other cell surface receptors that can be used for both diagnostic and therapeutic purposes.
New Trends in Brain Shuttle Peptides.
Prades R, Teixido M, Oller-Salvia B Mol Pharm. 2025; 22(3):1100-1109.
PMID: 39899901 PMC: 11881811. DOI: 10.1021/acs.molpharmaceut.4c01327.
Targeting Brain Drug Delivery with Macromolecules Through Receptor-Mediated Transcytosis.
Li Y, Liu R, Zhao Z Pharmaceutics. 2025; 17(1).
PMID: 39861756 PMC: 11769103. DOI: 10.3390/pharmaceutics17010109.
PepTune: Generation of Therapeutic Peptides with Multi-Objective-Guided Discrete Diffusion.
Tang S, Zhang Y, Chatterjee P ArXiv. 2025; .
PMID: 39764410 PMC: 11703324.
Selective Transfection of a Transferrin Receptor-Expressing Cell Line with DNA-Lipid Nanoparticles.
Vinales I, Silva-Espinoza J, Medina B, Urbay J, Beltran M, Salinas D ACS Omega. 2024; 9(38):39533-39545.
PMID: 39346819 PMC: 11425831. DOI: 10.1021/acsomega.4c03541.
Polypeptides-Based Nanocarriers in Tumor Therapy.
You J, Guo Y, Dong Z Pharmaceutics. 2024; 16(9).
PMID: 39339228 PMC: 11435007. DOI: 10.3390/pharmaceutics16091192.